BPC-157: Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18 , 185".

Study context

Study design: Preclinical animal study
Population or model: Animal model; verify the species in the source

Research question

What does this source report about BPC-157, and what evidence model and limitations apply?

Limitations

Confirm the complete study design, intervention identity, population or model, outcomes, statistical context, and limitations in the linked source before approval.

Original source

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18 , 185".

Michalina Józwiak, Marta Bauer, Wojciech Kamysz, Patrycja Kleczkowska · Pharmaceuticals (Basel, Switzerland) · 2025

DOI 10.3390/ph18101451 PMID 41155566 PMCID PMC12567171animal

Source abstract

We wish to thank the Authors of the comment for their interest in our manuscript [...].

Open source record

Related product

Review the complete product page, COAs, specifications, and all approved research sources.

BPC 157 research page

This educational summary helps you review the cited source in context. The third-party article is not reproduced, and the citation does not imply endorsement of a related product.